Popular Articles
Benefits Of Grapefruit

Clostridium Difficile Infection: Strategic Approaches For Better Outcomes
In recent years, the epidemiology of Clostridium difficile infection (CDI) has been changing. This trend may be the result of antimicrobial use, infection control practices, or other factors. It is critical for healthcare professionals to be aware of the epidemiology of this virulent pathogen and apply evidence-based principles for diagnosis, treatment, and prevention.
generic viagra online
Genetically Engineered Bacteria Compute The Route
US researchers have created "bacterial computers" with the potential to solve complicated mathematics problems. The findings of the research, published in BioMed Central"s open access Journal of Biological Engineering, demonstrate that computing in living cells is feasible, opening the door to a number of applications. The second-generation bacterial computers illustrate the feasibility of extending the approach to other computationally challenging math problems.
News of the day
FDA Approves Generic Version Of Emergency Contraception Pills
FDA on Wednesday approved Watson Pharmaceuticals" generic version of the emergency contraceptive Plan B, the Wall Street Journal reports. The generic drug will be available without a prescription to women ages 18 and older on Aug. 24, when Duramed Pharmaceuticals" market exclusivity for Plan B expires (Kalish, Wall Street Journal, 6/25). The generic version will be available to women ages 17 and younger with a prescription, according to an FDA press release (FDA Web site, 6/24). Watson will market the generic version under the name Next Choice (AP/Washington Post, 6/24).A one-time use pack of the brand-name product, Plan B, currently costs $49.99 through the online retailer DrugStore.com. According to Bloomberg, generic drugs usually cost 30% to 80% less than brand-name versions (Larkin, Bloomberg, 6/24).
Sexual Health

New Jersey Senate Passes Bill Requiring Pharmacists To Tell Consumers If Generic Drugs Can Replace Brand-Name Prescriptions

The New Jersey Senate on Thursday unanimously passed legislation (A 2030) that would require pharmacists to inform consumers when they have substituted generic drugs for brand-name prescriptions, the Newark Star-Ledger reports. The General Assembly approved the legislation in February and it now moves to Gov. Jon Corzine (D).If Corzine signs the bill, the law would take effect within 180 days, making New Jersey the first state in the U.S. to have such a requirement. State Sen. Christopher Bateman (R) said, "We"re hoping that other states will follow our lead" (Megerian, Newark Star-Ledger, 5/22). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):